Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate for abnormal bleeding in etonogestrel implant users
RBR-38vmd97Not yet recruiting
- Sponsor
- Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in menstrual disorders comparing Ulipristal acetate with Placebo (2 arms). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ulipristal
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on RBR-38vmd97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-38vmd97.